Serologicals Shareholders Approve Millipore's $1.4B Buyout

Jul 12, 2006

NEW YORK (GenomeWeb News) - Serologicals shareholders have approved Millipore's buyout offer, Serologicals said today.

GenomeWeb News on April 25 reported Millipore's plan to acquire Serologicals for $1.4 billion. The shareholders will receive $31.55 per share in cash.

About 82 percent of shares outstanding voted in favor of the deal, the Atlanta-based company said.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.